Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation
In: Beneficial MicrobesSearch for other papers by B.P Ganesh in
Current site
Google Scholar
Search for other papers by J.F Richter in
Current site
Google Scholar
Search for other papers by M. Blaut in
Current site
Google Scholar
loh@dife.de
Search for other papers by G. Loh in
Current site
Google Scholar
Abstract
Enterococcus faecium NCIMB 10415 reduces diarrhoea incidence and duration in animals and human study subjects. We tested whether the strain is also capable of reducing chronic gut inflammation and aimed to identify mechanisms that are involved in possible probiotic effects. To identify health-promoting mechanisms of the strain, we used interleukin-10-deficient mice that spontaneously develop gut inflammation and fed these mice a diet containing NCIMB 10415 for 3, 8 and 24 weeks, respectively. Control mice were fed a diet which was identically composed but did not contain the strain. After 3 weeks of intervention the experimental animals were less inflamed in the caecum than the control animals. This effect was not observed in the colon and there were no differences between experimental and control mice at any other time point. The application of the strain was associated with higher expression levels of interferon gamma and interferon gamma-induced protein 10 after 3 and 24 but not after 8 weeks of feeding. No differences between the animals were observed in intestinal barrier function or intestinal microbiota composition. However, we observed a low abundance of the mucin-degrading bacterium Akkermansia muciniphilain the mice that were fed NCIMB 10415 for 8 weeks. These low cell numbers were associated with a significantly lower caecal inflammation score and improved paracellular permeability as compared to the NCIMB-treated mice that were killed after 3 and 24 weeks of intervention. In conclusion, NCIMB 10415 is not capable of reducing gut inflammation in the IL-10-/- mouse model. The exact role of A. muciniphila and of a possible interaction between this bacterium, NCIMB 10415 and the host in gut inflammation requires further investigation.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Broom, L.J., Miller, H.M., Kerr, K.G. and Knapp, J.S., 2006. Effects of zinc oxide and Enterococcus faecium SF68 dietary supplementation on the performance, intestinal microbiota and immune status of weaned piglets. Research in Veterinary Science 80: 45-54.
'Effects of zinc oxide and Enterococcus faecium SF68 dietary supplementation on the performance, intestinal microbiota and immune status of weaned piglets ' () 80 Research in Veterinary Science : 45 -54.
-
Burich, A., Hershberg, R., Waggie, K., Zeng, W., Brabb, T., Westrich, G., Viney, J.L. and Maggio-Price, L., 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. American Journal of Physiology – Gastrointestinal and Liver Physiology 281: G764-G778.
'Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice ' () 281 American Journal of Physiology – Gastrointestinal and Liver Physiology : G764 -G778.
-
Buydens, P. and Debeuckelaere, S., 1996. Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial. Scandinavian Journal of Gastroenterology 31: 887-891.
'Efficacy of SF 68 in the treatment of acute diarrhea ' () 31 A placebo-controlled trial. Scandinavian Journal of Gastroenterology : 887 -891.
-
Chaucheyras-Durand, F. and Durand, H., 2010. Probiotics in animal nutrition and health. Beneficial Microbes 1: 3-9.
'Probiotics in animal nutrition and health ' () 1 Beneficial Microbes : 3 -9.
-
Derrien, M., Van Baarlen, P., Hooiveld, G., Norin, E., Muller, M. and De Vos, W.M., 2011. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Frontiers in Microbiology 2: 166.
'Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila ' () 2 Frontiers in Microbiology : 166.
-
Frank, J.A., Reich, C.I., Sharma, S., Weisbaum, J.S., Wilson, B.A. and Olsen, G.J., 2008. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Applied and Environmental Microbiology 74: 2461-2470.
'Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes ' () 74 Applied and Environmental Microbiology : 2461 -2470.
-
Gerritsen, J., Smidt, H., Rijkers, G.T. and De Vos, W.M., 2011. Intestinal microbiota in human health and disease: the impact of probiotics. Genes and Nutrition 6: 209-240.
'Intestinal microbiota in human health and disease: the impact of probiotics ' () 6 Genes and Nutrition : 209 -240.
-
Gitter, A.H., Schulzke, J.D., Sorgenfrei, D. and Fromm, M., 1997. Ussing chamber for high-frequency transmural impedance analysis of epithelial tissues. Journal of Biochemical and Biophysical Methods 35: 81-88.
'Ussing chamber for high-frequency transmural impedance analysis of epithelial tissues ' () 35 Journal of Biochemical and Biophysical Methods : 81 -88.
-
Hoermannsperger, G., Clavel, T., Hoffmann, M., Reiff, C., Kelly, D., Loh, G., Blaut, M., Holzlwimmer, G., Laschinger, M. and Haller, D., 2009. Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One 4: e4365.
'Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation ' () 4 PLoS One : e4365.
-
Lodemann, U., Hubener, K., Jansen, N. and Martens, H., 2006. Effects of Enterococcus faecium NCIMB 10415 as probiotic supplement on intestinal transport and barrier function of piglets. Archives of Animal Nutrition 60: 35-48.
'Effects of Enterococcus faecium NCIMB 10415 as probiotic supplement on intestinal transport and barrier function of piglets ' () 60 Archives of Animal Nutrition : 35 -48.
-
Marteau, P.R., De Vrese, M., Cellier, C.J. and Schrezenmeir, J., 2001. Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition 73: 430S-436S.
'Protection from gastrointestinal diseases with the use of probiotics ' () 73 American Journal of Clinical Nutrition : 430S -436S.
-
Reiff, C., Delday, M., Rucklidge, G., Reid, M., Duncan, G., Wohlgemuth, S., Hormannsperger, G., Loh, G., Blaut, M., Collie-Duguid, E., Haller, D. and Kelly, D., 2009. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 15: 1721-1736.
'Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease ' () 15 Inflammatory Bowel Diseases : 1721 -1736.
-
Sanders, M.E., 2008. Probiotics: definition, sources, selection, and uses. Clinical Infectious Diseases 46 Suppl 2: S58-S61; discussion S144-S151.
-
Scharek, L., Guth, J., Filter, M. and Schmidt, M.F., 2007. Impact of the probiotic bacteria Enterococcus faecium NCIMB 10415 (SF68) and Bacillus cereus var. toyoi NCIMB 40112 on the development of serum IgG and faecal IgA of sows and their piglets. Archives of Animal Nutrition 61: 223-234.
'Impact of the probiotic bacteria Enterococcus faecium NCIMB 10415 (SF68) and Bacillus cereus var ' () 61 toyoi NCIMB 40112 on the development of serum IgG and faecal IgA of sows and their piglets. Archives of Animal Nutrition : 223 -234.
-
Scharek, L., Guth, J., Reiter, K., Weyrauch, K.D., Taras, D., Schwerk, P., Schierack, P., Schmidt, M.F., Wieler, L.H. and Tedin, K., 2005. Influence of a probiotic Enterococcus faecium strain on development of the immune system of sows and piglets. Veterinary Immunology and Immunopathology 105: 151-161.
'Influence of a probiotic Enterococcus faecium strain on development of the immune system of sows and piglets ' () 105 Veterinary Immunology and Immunopathology : 151 -161.
-
Szabo, I., Wieler, L.H., Tedin, K., Scharek-Tedin, L., Taras, D., Hensel, A., Appel, B. and Nockler, K., 2009. Influence of a probiotic strain of Enterococcus faecium on Salmonella enterica serovar Typhimurium DT104 infection in a porcine animal infection model. Applied and Environmental Microbiology 75: 2621-2628.
'Influence of a probiotic strain of Enterococcus faecium on Salmonella enterica serovar Typhimurium DT104 infection in a porcine animal infection model ' () 75 Applied and Environmental Microbiology : 2621 -2628.
-
Taras, D., Vahjen, W., Macha, M. and Simon, O., 2006. Performance, diarrhea incidence, and occurrence of Escherichia coli virulence genes during long-term administration of a probiotic Enterococcus faecium strain to sows and piglets. Journal of Animal Science 84: 608-617.
'Performance, diarrhea incidence, and occurrence of Escherichia coli virulence genes during long-term administration of a probiotic Enterococcus faecium strain to sows and piglets ' () 84 Journal of Animal Science : 608 -617.
-
Tarasova, E., Yermolenko, E., Donets, V., Sundukova, Z., Bochkareva, A., Borshev, I., Suvorova, M., Ilyasov, I., Simanenkov, V. and Suvorov, A.N., 2010. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics. Beneficial Microbes 1: 265-270.
'The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics ' () 1 Beneficial Microbes : 265 -270.
-
Vahjen, W., Taras, D. and Simon, O., 2007. Effect of the probiotic Enterococcus faecium NCIMB10415 on cell numbers of total Enterococcus spp., E. faecium and E. faecalis in the intestine of piglets. Current Issues in Intestinal Microbiology 8: 1-7.
'Effect of the probiotic Enterococcus faecium NCIMB10415 on cell numbers of total Enterococcus spp ' () 8 E. faecium and E. faecalis in the intestine of piglets. Current Issues in Intestinal Microbiology : 1 -7.
-
Wohlgemuth, S., Haller, D., Blaut, M. and Loh, G., 2009. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environmental Microbiology 11: 1562-1571.
'Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice ' () 11 Environmental Microbiology : 1562 -1571.
-
Wohlgemuth, S., Loh, G. and Blaut, M., 2010. Recent developments and perspectives in the investigation of probiotic effects. International Journal of Medical Microbiology 300: 3-10.
'Recent developments and perspectives in the investigation of probiotic effects ' () 300 International Journal of Medical Microbiology : 3 -10.
-
Wunderlich, P.F., Braun, L., Fumagalli, I., D'Apuzzo, V., Heim, F., Karly, M., Lodi, R., Politta, G., Vonbank, F. and Zeltner, L., 1989. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. Journal of International Medical Research 17: 333-338.
'Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea ' () 17 Journal of International Medical Research : 333 -338.
-
Yan, F., Cao, H., Cover, T.L., Whitehead, R., Washington, M.K. and Polk, D.B., 2007. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132: 562-575.
'Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth ' () 132 Gastroenterology : 562 -575.
-
Zeyner, A. and Boldt, E., 2006. Effects of a probiotic Enterococcus faecium strain supplemented from birth to weaning on diarrhoea patterns and performance of piglets. Journal of Animal Physiology and Animal Nutrition 90: 25-31.
'Effects of a probiotic Enterococcus faecium strain supplemented from birth to weaning on diarrhoea patterns and performance of piglets ' () 90 Journal of Animal Physiology and Animal Nutrition : 25 -31.
-
Zyrek, A.A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U. and Schmidt, M.A., 2007. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiology 9: 804-816.
'Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair ' () 9 Cell Microbiology : 804 -816.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 414 | 152 | 23 |
| Full Text Views | 24 | 4 | 0 |
| PDF Views & Downloads | 16 | 3 | 0 |
Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation
In: Beneficial MicrobesSearch for other papers by B.P Ganesh in
Current site
Google Scholar
PubMed
Search for other papers by J.F Richter in
Current site
Google Scholar
PubMed
Search for other papers by M. Blaut in
Current site
Google Scholar
PubMed
loh@dife.de
Search for other papers by G. Loh in
Current site
Google Scholar
PubMed
Abstract
Enterococcus faecium NCIMB 10415 reduces diarrhoea incidence and duration in animals and human study subjects. We tested whether the strain is also capable of reducing chronic gut inflammation and aimed to identify mechanisms that are involved in possible probiotic effects. To identify health-promoting mechanisms of the strain, we used interleukin-10-deficient mice that spontaneously develop gut inflammation and fed these mice a diet containing NCIMB 10415 for 3, 8 and 24 weeks, respectively. Control mice were fed a diet which was identically composed but did not contain the strain. After 3 weeks of intervention the experimental animals were less inflamed in the caecum than the control animals. This effect was not observed in the colon and there were no differences between experimental and control mice at any other time point. The application of the strain was associated with higher expression levels of interferon gamma and interferon gamma-induced protein 10 after 3 and 24 but not after 8 weeks of feeding. No differences between the animals were observed in intestinal barrier function or intestinal microbiota composition. However, we observed a low abundance of the mucin-degrading bacterium Akkermansia muciniphilain the mice that were fed NCIMB 10415 for 8 weeks. These low cell numbers were associated with a significantly lower caecal inflammation score and improved paracellular permeability as compared to the NCIMB-treated mice that were killed after 3 and 24 weeks of intervention. In conclusion, NCIMB 10415 is not capable of reducing gut inflammation in the IL-10-/- mouse model. The exact role of A. muciniphila and of a possible interaction between this bacterium, NCIMB 10415 and the host in gut inflammation requires further investigation.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 414 | 152 | 23 |
| Full Text Views | 24 | 4 | 0 |
| PDF Views & Downloads | 16 | 3 | 0 |
